Find Clinical Trials
An exploratory, open-label, single centre, phase II, proof of concept study of gevokizumab treatment in patients with Schnitzler syndrome.
Servier Protocol Code:
CL2-78989-018
Sponsor:
Institut de Recherches Internationales Servier (I.R.I.S)
EudraCT Number:
2013-002562-39
Find a recruiting site
Name:
Institut de Recherches Internationales Servier, Département des études cliniques
Phone number:
+33 1 55 72 60 00
Results
English (USA)Interventions / Treatments
The treatment(s) given to the participants in the study.
- Schnitzler syndrome
- GEVOKIZUMAB
- S078989
Other study id numbers
Other identification numbers the study may be known by.
- CL2-78989-018